D. Keith Grossman is a healthcare executive with a simple educational background; he earned his M.B.A. from Stanford Graduate School of Business. Born in 1968, he has led Neuro Corp (NVRO) as CEO from 2019 until January 2023. During his...
D. Keith Grossman is a healthcare executive with a simple educational background; he earned his M.B.A. from Stanford Graduate School of Business. Born in 1968, he has led Neuro Corp (NVRO) as CEO from 2019 until January 2023. During his tenure, D. Keith was focused on aligning the company’s goals with shareholder interests which led Neuro Corp to significant stock performance changes. One interesting financial strategy he employed was leaving behind bonuses in 2023 after retiring before the payment period. His total compensation for 2022 was a massive $17.77 million, showcasing the company's potential under his leadership. In a notable instance, he sold stocks worth around $17.5 million in a single month during 2020 when the company's stock prices were climbing. Before he retired, he was granted 300,000 performance stock units (PSUs) in 2022, which are expected to vest based on challenging stock price targets over three years. Keith’s focus on strategic performance metrics reflects a desire for consistent growth, emphasizing the importance of high standards in corporate governance.